NEW YORK, Dec. 26, 2017 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Omega Healthcare Investors, Inc. (NYSE:OHI) from February 8, 2017 through October 31, 2017, inclusive (the “Class Period”) of the important January 16, 2018 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Omega investors under the federal securities laws.
To join the Omega class action, go to http://rosenlegal.com/cases-1243.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, defendants during the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) the financial and operating results of certain of Omega’s operators were deteriorating; (2) as a result, certain of Omega’s operators were experiencing worsening liquidity issues that were significantly impacting the operators’ ability to make timely rent payments; and (3) consequently, certain of Omega’s direct financing leases were impaired and certain receivables were uncollectible. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 16, 2018. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://rosenlegal.com/cases-1243.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at [email protected] or [email protected].
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Since 2014, Rosen Law Firm has been ranked #2 in the nation by Institutional Shareholder Services for the number of securities class action settlements annually obtained for investors. Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
Kevin Chan, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 34th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]
www.rosenlegal.com


Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year
ANZ Shares Hit Record High After Strong Q1 Profit and Cost-Cutting Gains
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
How Marco Pharma International Preserves German Homeopathic Traditions in America 



